zi-mallen_fitzpatrick-fibrils

Fibrils (yellow) inside a sperm cell. Credit: (William Mallen / Fitzpatrick lab / Columbia's Zuckerman Institute)

Lab Tests Show Sperm Absorb Alzheimer’s-Like Clumps That Carry RNA

In A Nutshell

  • Semen makes amyloid fibrils, clumps best known from Alzheimer’s, that latch onto RNA.
  • In lab tests, sperm absorbed lab-made fibrils.
  • In mouse fertilization experiments, fibril-carried RNA reached early embryos.
  • Effects on children, including any diet link, remain untested.

Amyloid has a nasty reputation. It is the sticky protein buildup found in the brains of Alzheimer’s patients. Semen, it turns out, makes its own version, and lab experiments suggest it helps carry RNA, the molecule cells use to read genetic instructions, toward an embryo. That could be one way a father’s diet reaches his children.

A study in Molecular Cell found that semen contains naturally occurring amyloid fibrils, thread-like protein clumps that latch onto bits of RNA. In lab tests, sperm absorbed lab-made versions of them. In mouse fertilization experiments done in a lab dish, RNA riding on the fibrils showed up in early embryos, where a test RNA was turned into protein.

Researchers already knew that male mice fed high-fat diets carry altered RNA in their sperm, and that their pups show metabolic changes. How that RNA gets onto sperm has been a puzzle. The new work points to a possible route. It did not test diet, though, or any effect on offspring health.

Semen Proteins Grab RNA and Harden Into Amyloid Fibrils

Researchers from Columbia University and partner institutions focused on a fragment of a protein the prostate releases into semen. The fragment carries a strong positive charge, RNA carries a negative one, and the two cling together like magnets. Sperm meet these proteins during ejaculation, before their long trip toward an egg.

In a test tube, the pair gathered into liquid blobs, much like oil beading up in vinegar, even when human seminal fluid was added. Over about three days, those blobs hardened into amyloid fibrils. Adding RNA made the process far faster, and longer RNA strands sped it up more.

To confirm that semen makes these fibrils on its own, the team purified them from pooled semen bought from anonymous, healthy donors. The fibril material held the same prostate protein, plus small RNA fragments, the largest group being snippets of the RNA that helps cells build proteins.

Amyloid Fibrils Deliver RNA to Embryos
Semen’s amyloid clumps latch onto RNA and enter sperm, a possible route for a father’s influence on his children. (Image by StudyFinds)

Amyloid Fibrils Enter Sperm Cells From Cows, Mice, and Humans

Next came the question of whether sperm actually take the clumps in. Cow sperm, larger and easier to study, went first. The team attached tiny gold beads to lab-made fibrils so they would show up in 3D images of frozen sperm. Fibrils turned up in the midsection, the energy-making part, touching structures inside the cell. Only five of 74 prepared slices showed fibrils, and just two were clear enough to be certain, so the team added other methods.

Live video helped. Tagged fibrils crossed the outer membrane of cow sperm and settled inside within 45 minutes, and about 95% of the cow sperm tested contained them. Fibrils also built up inside mouse and human sperm, though no percentage was reported for those.

Human sperm were a tougher test. A different method, run on live human sperm, found only 2.44% took up fibrils, a number the researchers say may undercount because of conservative settings. When an enzyme stripped proteins off the sperm’s surface, that figure fell to 0.30%. That points to surface proteins as a possible way in, though none were identified.

Amyloid Fibrils Deliver RNA to Mouse Embryos in Lab Fertilization

Mouse sperm were exposed to human fibrils, then used to fertilize mouse eggs in a dish. Pieces of the human protein turned up in the sperm and in the resulting embryos, which were only two cells old. In a second round, glowing tagged fibrils were visible in about 20% of embryos.

Tracking RNA was the next test. With a traceable, lab-made RNA attached to the fibrils, embryos from fibril-exposed sperm held measurably more of it, based on three samples per group. A protein called clusterin, already present in semen, sperm, and embryos, loosened RNA from fibrils about twice as fast in test tubes, hinting at how the cargo gets released.

A final experiment used RNA carrying instructions for a glowing marker protein. Embryos from fibril-exposed sperm contained at least ten times more of that protein, measured with a technique that identifies molecules by weight. Some of the protein also appeared without fibrils, possibly from loose RNA slipping in on its own.

Amyloid Fibrils Hint at a Non-Viral Way to Deliver Genes

Gene therapies that use viruses as delivery trucks can trigger immune reactions. The authors say amyloid fibrils could, in theory, offer a virus-free option for delivering genetic material at fertilization, perhaps for families at high risk of passing on a genetic disorder. That is far from any clinic, and editing embryos would raise serious ethical questions of its own.

Every sperm and embryo experiment here used lab-made fibrils, and the RNA tests used RNA added from outside. Whether RNA found naturally in semen reaches embryos this way remains untested.

Amyloid’s bad reputation may be undeserved in at least one corner of the body. Whether these clumps also carry a father’s influence to his children is the question that will decide if the discovery matters.


Disclaimer: This article is informational only, not medical advice. It covers early laboratory research. Consult a health professional about personal health questions.


Paper Notes

Limitations

Freezing-based imaging (cryo-electron tomography) relied on cells preselected by a fluorescent marker, so it could not show what share of sperm hold fibrils; the authors leaned on other imaging methods instead. Fluorescence imaging and cell sorting produced very different uptake estimates, and the authors suggest the conservative settings in the sorting method likely undercounted, so true uptake is hard to pin down. No commercially available antibody recognizes the prostate protein fragment studied, which limited isolation of natural fibrils and their binding partners. The antibody the team built was an IgM type, which is harder to use for pulling out molecules. The sperm and embryo experiments used synthetic fibrils, the RNA tests used added RNA, and the authors say other RNA types may bind and release differently. They also note that how fibrils move from sperm into the embryo remains unknown, and that the sperm-surface entry route is unidentified.

Funding and Disclosures

Research in the Sidoli laboratory was supported by the Hevolution Foundation (AFAR), the ERC-CFAR Center for AIDS Research, the Einstein-Mount Sinai Diabetes Center, and the NIH Office of the Director. The Liang laboratory acknowledged the NYU Langone Health Microscopy Laboratory, partly funded by an NIH Cancer Center Support Grant. The Vagelos Precision Medicine Fund supported Anthony W.P. Fitzpatrick, William S. Mallen, and the research project. The authors declare no competing interests.

Publication Details

The study, titled “Amyloid-mediated RNA uptake by sperm for embryonic delivery,” was written by William S. Mallen, Nataliya Zabello, Susan Brenner-Morton, Simone Sidoli, Feng-Xia Liang, Joseph Sall, Jason Yin, Priyanka Mathews, Mengmeng Zhu, Guoan Zhang, Carolyn L. Lee, Ya-Cheng Liao, and Anthony W.P. Fitzpatrick, the lead contact and corresponding author ([email protected]). The authors are affiliated with Columbia University, Albert Einstein College of Medicine, New York University Grossman School of Medicine, and Weill Cornell Medicine. The paper appears in Molecular Cell, Volume 86, in the issue dated November 19, 2026, and was published online ahead of that issue by Cell Press (Elsevier Inc.) under an open-access license (CC BY-NC-ND). It was received January 7, 2026, and accepted October 5, 2026. DOI: https://doi.org/10.1016/j.molcel.2026.10.004. Citation: Mallen, W.S., et al. (2026). Amyloid-mediated RNA uptake by sperm for embryonic delivery. Molecular Cell, 86, 1-16.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor